When axSpA does not respond to treatment and both the clinician and patient perceive this is a problem, we call it difficult to manage. Is the disease difficult, or are we failing to see it clearly?
The content at ACR Orlando was vast. I looked at several posters/listened to many talks and heard from colleagues. Here is my list TOP 6 practice changing themes.
Dr. Cush reviews best reasons to go to ACR annually, but also the best way to learn ACR26 content this year.
Randomized trials typically get top billing at ACR Convergence, but the past three years have seen “target trial emulations” land coveted plenary sessions and oral abstracts. These are not actually trials; instead, they are a new-ish approach to generating causal inferences from observational
